Variations in the serotonin transporter gene SLC6A4 directly affect how patients respond to citalopram according to a Mayo Clinic Study just released in the current issue of the American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.
Researchers examined the serotonin transporter gene, or SLC6A4, in 1,914 study participants. The study showed that two variations in [...]
Filed under: Personalized Medicine, Pharmacogenetics | 1 Comment »
